Top

Journal of Clinical Immunology

Published in:

01-05-2018 | Letter to Editor

Disseminated Cutaneous Warts in X-Linked Hyper IgM Syndrome

Authors: Hsi-en Ho, Minji Byun, Charlotte Cunningham-Rundles

Published in: Journal of Clinical Immunology | Issue 4/2018

Excerpt

To the Editor: …

Available only for authorised users

Davies EG, Thrasher AJ. Update on the hyper immunoglobulin M syndromes. Br J Haematol. 2010;149:167–80.CrossRefPubMedPubMedCentral

Cabral-Marques O, Ramos RN, Schimke LF, Khan TA, Amaral EP, Barbosa Bomfim CC, et al. Human CD40 ligand deficiency dysregulates the macrophage transcriptome causing functional defects that are improved by exogenous IFN-γ. J Allergy Clin Immunol. 2017;139:900–12.CrossRefPubMed

Cabral-Marques O, Arslanian C, Ramos RN, Morato M, Schimke L, Soeiro Pereira PV, et al. Dendritic cells from X-linked hyper-IgM patients present impaired responses to Candida albicans and Paracoccidioides brasiliensis. J Allergy Clin Immunol. 2012;129:778–86.CrossRefPubMed

Leven EA, Maffucci P, Ochs HD, Scholl PR, Buckley RH, Fuleihan RL, et al. Hyper IgM syndrome: a report from the USIDNET Registry. J Clin Immunol. 2016;36:490–501.CrossRefPubMedPubMedCentral

Cabral-Marques O, Klaver S, Schimke LF, Ascendino ÉH, Khan TA, Pereira PV, et al. First report of the hyper-IgM syndrome registry of the Latin American Society for Immunodeficiencies: novel mutations, unique infections, and outcomes. J Clin Immunol. 2014;34(2):146–56.CrossRefPubMed

Leiding JW, Holland SM. Warts and all: human papillomavirus in primary immunodeficiencies. J Allergy Clin Immune. 2012;130:1030–48.CrossRef

Chang MW, Romero R, Scholl PR, Paller AS. Mucocutaneous manifestations of the hyper-IgM immunodeficiency syndrome. J Am Acad Dermatol. 1998;38:191–6.CrossRefPubMed

Reid TM, Fraser NG, Kernohan IR. Generalized warts and immune deficiency. Br J Dermatol. 1976;95:559–64.CrossRefPubMed

Lynn J, Knight AK, Kamoun M, Levinson AI. A 55-year-old man with hypogammaglobulinemia, lymphopenia, and unrelenting cutaneous warts. J Allergy Clin Immunol. 2004;114:409–14.CrossRefPubMed

10.

Jain A, Atkinson TP, Lipsky PE, Slater JE, Nelson DL, Strober W. Defects of T-cell effector function and post-thymic maturation in X-linked hyper-IgM syndrome. J Clin Invest. 1999;103:1151–8.CrossRefPubMedPubMedCentral

11.

Ostenstad B, Giliani S, Mellbye OJ, Br N, Abrahamsen T. A boy with X-linked hyper-IgM syndrome and natural killer cell deficiency. Clin Exp Immunol. 1997;107:230–4.CrossRefPubMedPubMedCentral

Title: Disseminated Cutaneous Warts in X-Linked Hyper IgM Syndrome
Authors: Hsi-en Ho
Minji Byun
Charlotte Cunningham-Rundles
Publication date: 01-05-2018
Publisher: Springer US
Published in: Journal of Clinical Immunology / Issue 4/2018
Print ISSN: 0271-9142
Electronic ISSN: 1573-2592
DOI: https://doi.org/10.1007/s10875-018-0505-z

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Disseminated Cutaneous Warts in X-Linked Hyper IgM Syndrome

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 4/2018

Treatment of Intracerebral Lesions with Abatacept in a CTLA4-Haploinsufficient Patient

T+ NK+ IL-2 Receptor γ Chain Mutation: a Challenging Diagnosis of Atypical Severe Combined Immunodeficiency

Insights into Mutation Effect in Three Poikiloderma with Neutropenia Patients by Transcript Analysis and Disease Evolution of Reported Patients with the Same Pathogenic Variants

Dual Threat of Epstein-Barr Virus: an Autopsy Case Report of HIV-Positive Plasmablastic Lymphoma Complicating EBV-Associated Hemophagocytic Lymphohistiocytosis

Aortic Calcification in a Patient with a Gain-of-Function STAT1 Mutation

Correction to: Assessment of Local Adverse Reactions to Subcutaneous Immunoglobulin (SCIG) in Clinical Trials

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page